| Income Statement |
| Operating Expenses | 1.80M |
|
| Research and Development Expense | 61.00K |
| Selling, General and Administrative Expense | 1.74M |
| Operating Income | -1.80M |
| Net Income | -1.62M |
| Net Income Common Stock | -1.62M |
| Net Income Common Stock (USD) | -1.62M |
| Consolidated Income | -1.62M |
| Earnings per Basic Share | -0.14 |
| Earnings per Basic Share (USD) | -0.14 |
| Earnings per Diluted Share | -0.14 |
| Earning Before Interest & Taxes (EBIT) | -1.62M |
| Earning Before Interest & Taxes (USD) | -1.62M |
| Weighted Average Shares | 11.87M |
| Weighted Average Shares Diluted | 11.87M |
| Balance Sheet |
| Cash and Equivalents | 1.76M |
| Cash and Equivalents (USD) | 1.76M |
| Investments | 7.00M |
| Investments Current | 7.00M |
| Current Assets | 12.32M |
| Total Assets | 12.32M |
| Current Liabilities | 1.56M |
| Total Liabilities | 1.56M |
| Accumulated Retained Earnings (Deficit) | -696.52M |
| Shareholders Equity | 10.76M |
| Shareholders Equity (USD) | 10.76M |
| Trade and Non-Trade Payables | 1.04M |
| Cash Flow |
| Net Cash Flow from Financing | 4.10M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.79M |
| Net Cash Flow from Investing | -7.00M |
| Net Cash Flow - Investment Acquisitions and Disposals | -7.00M |
| Net Cash Flow from Operations | -2.89M |
| Share Based Compensation | -471.00K |